Pharmaceutical Industry to Help Excipients Sales in Latin America to Gain Remarkably, Forecasts Tmr

Transparency Market
Research
Excipients Market - Latin America Industry Analysis,
Size, Share, Growth, Trends, and Forecast 2015 - 2023

Published Date
10-May-2016

284 Page Report

Buy Now

Request Sample

Press Release

Pharmaceutical Industry to Help Excipients Sales in Latin America
to Gain Remarkably, forecasts TMR
Transparency Market Research
State Tower,
90, State Street, Suite 700.
Albany, NY 12207
United States
www.transparencymarketresearch.com
sales@transparencymarketresearch.com

Excipients Market

REPORT DESCRIPTION
Excipients Market - Latin America Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 2023
The top three participants in the Latin America excipients market, Ashland Inc., BASF SE, and FMC
Corporation, hold a collective share of 26.2% in the market in 2014. Ashland Inc. will focus on restructuring its
global programs and integrating centralized supply chains for retaining its competitive edge in the overall
market, TMR expects. On the other hand, BASF SE and FMC Corporation are investing in result-driven
research and development to introduce effective products to their existing product portfolio.
In the coming years, in addition to catering to the pharmaceutical industry, the players in the Latin America
excipients market will expand the applications of their excipients to improve revenues, expects TMR.
Get FREE Sample Of This Report : http://www.transparencymarketresearch.com/sample/sample.php?
flag=S&rep_id=10883
Pharmaceutical Industry Backs Progress of Excipients Market
The Latin America excipients market is mainly being driven by the booming pharmaceuticals industry that uses
excipients as flavoring agents, binders, disintegrants agents for making tablets, capsules, and other forms of
drugs. The research states that the pharmaceutical industry in Latin America will progress at a CAGR of 8.1%
in terms of revenue between 2015 and 2023. The increasing population of geriatrics is acting as a fulcrum for
the pharmaceutical...